Juhasz2022 - In silico evaluation of Paxlovid’s pharmacometrics for SARS-CoV-2
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
Paxlovid is a promising, orally bioavailable novel drug for SARS-CoV-2 with excellent safety profiles. Our main goal here is to explore the pharmacometric features of this new antiviral. To provide a detailed assessment of Paxlovid, we propose a hybrid multiscale mathematical approach.
创建时间：
2024-02-28
